BSL4 Core
BSL4 Core
批准号:
7649747
负责人:
Clarence J. Peters
金额:
$19.1万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-03-01 至 2009-02-28
关键词:
AerosolsAnimal ModelAnimalsBiomedical ResearchContainmentDiagnosticEvaluationFoundationsHousingKnowledgeLaboratoriesMechanicsMedicalMicrobiologyModelingMulti-Drug ResistanceOperative Surgical ProceduresPurposeResearchResearch InfrastructureResearch PersonnelRodentSamplingScheduleScientistTestingTexasTherapeuticTrainingUniversitiesVaccinesViral Hemorrhagic FeversWorkWorkplaceexperiencehemorrhagic fever virusnonhuman primatepathogenic bacteriaresearch studytherapeutic vaccine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This BSL-4 core provides the infrastructure to permit safe work to be performed on aerosol-infectious,
potentially lethal agents. It consists of the mechanical safeguards of two high-containment laboratories,
the provision of training in BSL-4 operations, and assistance in operations within the laboratories. Generally,
the investigators will work within the laboratory, but about 20% of the effort will be devoted to challenge
experiments using established animal models to test newly developed vaccines and therapeutics. Part of
this core is located at Southwest Foundation for Biomedical Research (SF BR) in San Antonio, TX where
1200 ft 2 of BSL-4 laboratory space is available. The other component is scheduled for completion in June,
2003 and will provide 2000 ft 2 at the University of Texas Medical Branch, Galveston, TX. The SFBR facility
has been in operation since March of 2000 and provides space for microbiological operations as well as
housing for rodents and small non-human primates. UTMB will have 1000 ft 2devoted primarily to animals
and 1000 ft 2 mainly used to for microbiology. Both have access to a high intensity gamma irradiator allowing
inactivation of samples for further analysis outside the BSL-4 laboratory. This core is essential for work on
the hemorrhagic fever viruses and multidrug resistant highly pathogenic bacteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rift Valley Fever Vaccine Development of Animal Models and Optimize Production
-
批准号:7623932
-
项目类别:
-
资助金额:$128.26万
-
财政年份:2008
-
负责人:Clarence J. Peters
-
依托单位:
Rift Valley Fever Vaccine Development of Animal Models and Optimize Production
-
批准号:7860454
-
项目类别:
-
资助金额:$43.11万
-
财政年份:2008
-
负责人:Clarence J. Peters
-
依托单位:
Rift Valley Fever Vaccine Development of Animal Models and Optimize Production
-
批准号:7455452
-
项目类别:
-
资助金额:$84.0万
-
财政年份:2008
-
负责人:Clarence J. Peters
-
依托单位:
Passive Immunotherapeutics for Select Agents
-
批准号:7649817
-
项目类别:
-
资助金额:$26.93万
-
财政年份:2008
-
负责人:Clarence J. Peters
-
依托单位:
Infectious Diseases From Nature: Mclaughlin Symposium
-
批准号:6760836
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2004
-
负责人:Clarence J. Peters
-
依托单位:
Rift Valley Fever Virus MP-12 Vaccine Completion
-
批准号:6845770
-
项目类别:
-
资助金额:$565.31万
-
财政年份:2004
-
负责人:Clarence J. Peters
-
依托单位:
EPIZOOTIOLOGY OF MACHUPO VIRUS IN BOLIVIA
-
批准号:6201308
-
项目类别:
-
资助金额:$12.49万
-
财政年份:1999
-
负责人:Clarence J. Peters
-
依托单位:
EPIZOOTIOLOGY OF MACHUPO VIRUS IN BOLIVIA
-
批准号:6216439
-
项目类别:
-
资助金额:$12.49万
-
财政年份:1999
-
负责人:Clarence J. Peters
-
依托单位:
EPIZOOTIOLOGY OF MACHUPO VIRUS IN BOLIVIA
-
批准号:6100086
-
项目类别:
-
资助金额:$12.49万
-
财政年份:1998
-
负责人:Clarence J. Peters
-
依托单位:
EPIZOOTIOLOGY OF MACHUPO VIRUS IN BOLIVIA
-
批准号:6235505
-
项目类别:
-
资助金额:$12.01万
-
财政年份:1997
-
负责人:Clarence J. Peters
-
依托单位:
EPIZOOTIOLOGY OF MACHUPO VIRUS IN BOLIVIA
-
批准号:5206010
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Clarence J. Peters
-
依托单位:--
海外基金